Document Detail


The science of lipidology impacts underwriting and improves mortality.
MedLine Citation:
PMID:  20377099     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Substantial change in how we think about lipids and atherosclerosis is on the afoot. Discoveries in lipidology are changing the relative importance of commonly used lipid markers, and indentifying new lipid markers for premature disease, new targets for treatment, and new treatment regimens. These advances in lipid science will definitely change clinical practice. They will also force life insurance medical directors to write new underwriting guidelines and consider new testing paradigms. At a minimum, the new science of lipidology offers an opportunity for alert medical directors to substantially improve risk classification and selection.
Authors:
Robert Gleeson
Related Documents :
20595319 - Presentation of the 2009 morris f collen award to betsy l humphreys, with remarks from ...
12086289 - Cyclooxygenase-2-selective inhibitors: translating pharmacology into clinical utility.
1383949 - In search of a perfect partnership.
17048779 - A pioneer from the islamic golden age: haly abbas and spinal traumas in his principal w...
7995229 - Vision and cognition in the natural philosophy of albert the great (albertus magnus).
17130619 - "everyone knew but no one had proof": tobacco industry use of medical history expertise...
14629119 - Fungal lectin, xcl, is internalized via clathrin-dependent endocytosis and facilitates ...
8732919 - Respiratory health in asbestos-exposed ironworkers.
25160249 - Sublanguage analysis of medical weblogs.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of insurance medicine (New York, N.Y.)     Volume:  41     ISSN:  0743-6661     ISO Abbreviation:  J Insur Med     Publication Date:  2009  
Date Detail:
Created Date:  2010-04-09     Completed Date:  2010-04-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8401468     Medline TA:  J Insur Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  197-200     Citation Subset:  T    
Affiliation:
drbobgleeson@msn.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Atherosclerosis / blood,  prevention & control
Cardiovascular Diseases / blood,  mortality*,  prevention & control
Humans
Hyperlipidemias / blood,  drug therapy
Insurance, Life / statistics & numerical data*
Lipids / blood*
Risk Assessment
Chemical
Reg. No./Substance:
0/Lipids

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Rating the raters: evaluating the predictions from a life expectancy rating service.
Next Document:  Moyamoya disease: review of the literature and estimation of excess morbidity and mortality.